Eggshell Membrane Formulations for Joint Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for joint pain, such as osteoarthritis and rheumatoid arthritis, do not adequately address the need for effective, synergistic combinations of natural ingredients to improve joint mobility, reduce discomfort, and promote antioxidant activity.
Innovation Solution
A composition combining fowl eggshell membrane with hyaluronic acid, astaxanthin, and other active constituents like gamma-linoleic acid, omega-3 fatty acids, and anti-inflammatory compounds in an oral dosage form, specifically formulated to enhance water solubility and bioavailability, is administered to alleviate joint pain symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional single-ingredient treatments are used for joint pain, then the treatment approach is simple, but the effectiveness in reducing joint pain and inflammation is insufficient
Solution Approach 1:
The patent combines multiple active ingredients (eggshell membrane, hyaluronic acid, astaxanthin, gamma-linoleic acid, omega-3 fatty acids, and anti-inflammatory compounds) into a single synergistic composition. This merging of ingredients addresses the insufficiency of single-ingredient treatments by creating a multi-component formulation that targets joint pain through multiple mechanisms simultaneously, thereby improving effectiveness while maintaining a practical single-product delivery system.
Solution Approach 2:
The invention creates a composite material formulation that integrates six different classes of active constituents with complementary mechanisms of action. This composite approach allows the treatment to address inflammation, pain, oxidative stress, and joint mobility simultaneously, resolving the contradiction between treatment simplicity and effectiveness by providing a multi-functional composite solution.
2Object-affected harmful factors
If natural ingredients are used to treat joint pain, then the treatment is safer with fewer side effects, but the bioavailability and absorption of these ingredients is limited
Solution Approach 1:
The patent employs parameter changes by utilizing ingredients in specific molecular weight ranges (hyaluronic acid: 0.5-100 KDa) and specific dosage formulations to optimize bioavailability. The composition is designed to enhance water solubility and absorption rates of the natural ingredients, thereby improving the quantity of active substance that reaches target tissues while maintaining the safety profile of natural components.
Solution Approach 2:
The formulation uses hyaluronic acid as a key intermediary component that not only provides therapeutic benefit but also enhances the delivery and absorption of other active ingredients. The synergistic combination acts as a mediator system where components work together to improve mutual bioavailability, resolving the contradiction between using safe natural ingredients and achieving sufficient therapeutic concentrations.
3Reliability
If multiple active ingredients are combined in a synergistic formulation, then the therapeutic effectiveness is enhanced, but the manufacturing complexity and formulation challenges increase
Solution Approach 1:
The patent segments the complex multi-ingredient formulation into distinct functional modules, each contributing specific therapeutic properties. This segmentation approach allows for systematic formulation development and quality control of each component while maintaining the overall synergistic effect, thereby reducing manufacturing complexity compared to developing a completely new multi-component system.
Data Source
AI summary
A method to treat and alleviate symptoms of joint pain in an individual is accomplished by administering a therapeutic amount of fowl eggshell membrane or processed eggshell membrane preparations in synergistic combination with other active constituents in an oral dosage form.